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nfection using several methods including serological tests,
icroscopy, PCR.
Results: Nineteen (32.2%) patients had positive results
or VL after one or more of the tests performed, while only
patients (11.8%) had positive results with all the tests
ncluding Giemsa stain. Four (6.8%) patients had negative
esults based on all the serological tests performed except
or positive results with Giemsa stain, culture and PCR. The
ther 4 (6.8%) patients had positive results with Formol-
el, ELISA IgG (>1.1 ISR) and IFAT IgG, (>1/256) but negative
esults were obtained with direct microscopic examination,
ulture and PCR. Using PCR Leishmania infantum DNA was
etected in 11(18.6%) of the (Leishmania) cultures origi-
ated from the bonemarrow samples. Plasmodium vivaxwas
ound in 2 (3.4%) patients and leptospira was detected in 1
1.7%) patient. One (1.7%) patient was diagnosed with Pneu-
onia (Streptococcus pneumoniae). Forty (67.8%) patients
ad negative results after direct microscopic examination,
ulture, serological tests and PCR. The kappa coefﬁcients
= 0.80 K = 1.00, K = 0.51, K = 0.55 and K = 0.45 were evalu-
ted for PCR and direct microscopic examination, PCR and
ulture, PCR and ELISA, PCR and IFAT and PCR and Formol-
el, as perfect agreement, perfect agreement, moderate
greement and moderate agreement fair moderate, respec-
ively. The probability values (p) for comparisons of all
he above tests with PCR showed a signiﬁcant correlation
p < 0.000)
Conclusion: In conclusion, we found that no single
ethod alone was sufﬁcient enough to diagnose VL accu-
ately; however, combined with PCR, all these methods can
eveal better and sensitive results ultimately leading to a
orrect diagnosis. We also suggest that PCR has to be applied
ith other laboratory diagnostic tests in order to increase
he sensitivity in diagnosis and decrease the possible defects
n diagnosis.
oi:10.1016/j.ijid.2010.02.596
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mmunological proﬁle of CD18-deﬁcient mice during
chistosoma mansoni infection
.S. Espíndola ∗, F.G. Frantz, L.H. Faccioli
Universidade de São Paulo, Faculdade de Ciências Farma-
êuticas de Ribeirão Preto, Ribeirão Preto, SP, Brazil
Background: Schistosomiasis is recognized as the most
mportant human helminth infection in terms of morbidity
nd mortality harboring around 200 million people world-
ide, beeing cosidered a risk for travelers. A study focusing
he role of integrins, which are involved on cellular migra-
ion, antigen presentation and T cell activation, is necessary
n the knowledge of immunopathology during schistoso-
iasis. The aim of this work is to evaluate the role of
D18 molecule, a 2 integrin, in modulate the immune
esponse and pathology during the development of exper-
mental schistosomiasis.
Methods: C57BL/6 (WT) mice and CD18low mice were
ercutaneously infected with 50 cercariae and the para-
itological evaluation was done 48 days after infection. The
dult worms were recovered from the hepatic portal system
nd the liver by perfusion with citrate saline. Ten and 48 days
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fter infection, the cellular recruitment to the bronchoalve-
lar lavage ﬂuid (BALF), as well the number of inﬂammatory
ells present on the peripheral blood and the cytokines
roduction in the lung homogenates were evaluated. To
etermine the proliferation of T CD3+CD4+ cells and the
ytokines production in vitro, splenocytes were stimulated
ith concanavalin-A.
Results: CD18low mice showed an increased suscepti-
ility to infection with S. mansoni since the worm burden
as 135% higher than in the WT group. Nevertheless, the
ellular recruitment to the BALF was similar between WT
nd CD18low mice, while CD18low mice showed a markedly
nhancement on the accumulation of mononuclear cells
n the peripheral blood, suggesting that less effector cells
ould migrate through blood to the inﬂammatory focus.
oreover, T cells from CD18low mice presented reduced
otential to proliferate in the presence of Con-A than cells
rom infected WT mice. Ten days after infection the mea-
urement of TNF-, IL-12, IL-5, IL-10 and IL-4 in the lung
omogenates was always lower in CD18low mice. Although,
8 days after infection, only IL-5 and IL-12 in CD18low mice
howed slightly inferior levels. After in vitro stimulation of
plenocytes with Con-A, just IL-5 production from CD18low
ice was lower than WT.
D18 low mice are more susceptible to infection with S.
ansoni than WT mice. Worm burden was obtained by
erfusion of the hepatic portal system with citrate saline.
* p <0.01
Conclusion: The deﬁciency of CD18 molecule causes an
ncontrolled parasite burden and changes of immune pat-
erns, magnifying the severity of disease.
oi:10.1016/j.ijid.2010.02.597
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ontrol of Chagas disease patients whith chronic form of
ts treatment after Benznidazole treatment
.T. Fraile Farin˜as1,∗, C. Parada Barba2, J.L. Ramos Marti 3,
. Chanza Avino3, M. Garcia Rodriguez3, C. Gimeno
ardona3
Hospital General Universitario de Valencia, Valencia, Spain
Centro de transfusion de la CV, Valencia, Spain
CHGUV, Valencia, SpainBackground: Chagas disease is caused by the parasite
rypanosoma cruzi (TC). It’s estimated that around sixteen
illion people are infected in Latin America and represents
serious blood safety problem due to increasing immigra-
ion from these countries. Following the acute phase of the
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infection, untreated Chagas’disease enters a chronic phase
that is initially asymptomatic or unrecognized. Between 20-
30% of patients develop cardiac abnormalities, 10% digestive
complaints, and less than 5% of patients develop a neurologic
form of disease. The aim of this work is to determiner the
effect of Benznidazol treatment (5mg/kg/day) 60 days, in
patients with chronic Chagas disease.
Methods: In 53 samples of patients we were tested
by enzyme linked immunoassay (ELISA Dade Behring
CHAGO560DB) for IgG antibodies against TC, and indirect
immunoﬂuorescence (IFI Biocientiﬁca SA Immunoﬂuor Cha-
gas NF09-60) as conﬁrmatory tes, for IgG (Bio-Merieux 75
692) antibodies, with serial serum dilutions to determine
the level of these antibodies. In addition, all PCR were per-
formed before treatment and at the end of it. As a criterion
of cure was established a signiﬁcant (more than 2 degrees)
in the rate of antibody after treatment.
Results: About the 53 patients studied, 37 were per-
formed two or more determinations of antibodies before
and after treatment and in 80% of them, a diminution of the
levels were found. The PCR was negative after treatment
in all cases. In 13 patients was carried out only antibody
titer before treatment, administering it even with low rates
from them, because they had organ involvement suggestive
of Chagas.
Conclusion: More studies are needed to clearly establish
the criteria for cure of Chagas disease.
Furthermore, because in these patients with chronic Cha-
gas disease parasitaemia sometimes is intermittent and low
have to question the result of a negative PCR.
doi:10.1016/j.ijid.2010.02.598
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Population structure of Leishmania infantum from
Morocco
H. Salsabil 1, A. Amro2, G. Schönian3, L. Meryem1,∗
1 Institut Pasteur du Maroc, Casablanca, Morocco
2 Faculty of Pharmacy, Al-Quds University, Jerusalem,
Palestina
3 Charité Universitätsmedizin. Institut für Mikrobiologie
und Hygiene, Berlin, Germany
Background: Visceral leishmaniasis (VL) is endemic in
northern Morocco where it is caused by Leishmania infan-
tum. It predominantly affects children under 4 years with
incidence of 100 cases/year. Genetic variability and popula-
tion structure has been investigated for 55 strains isolated
from infected dogs and humans in Morocco.
Methods: A multilocus microsatellite typing (MLMT)
approach was used in which a MLM type based on size varia-
tion in 14 independent microsatellite markers was compiled
for each strain. MLMT proﬁles of 21 European strains which
belonged to zymodeme MON-1 and non-MON1 according to
multilocus enzyme electrophoresis (MLEE) were included for
comparison.
Results: A Bayesian model-based approach and phylo-
genetic analysis based on genetic distances inferred two
populations of the Moroccan L. Infantum; population A con-
sists of 25 strains and population B consists of 30 strains.
Theses populations were signiﬁcantly different from the
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uropean MON 1 and Non MON 1 strains which constructed
wo different populations respectively.
Gene ﬂow was noticed between populations A and B. Five
trains have shown mixed A B genotype indicating possible
ecombination between the two populations
Conclusion: No genetic differences were detected
etween parasites isolated from dogs and humans empha-
izing the role of dogs as reservoir. MLMT has proven to be
powerful tool for epidemiological and population genetic
nvestigations in Leishmani.
oi:10.1016/j.ijid.2010.02.599
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ropolis and derivatives of megazol: In vitro and in vivo
ctivity on Trypanosoma cruzi, mechanism of action and
electivity
. Salomão1,∗, E.M. De Souza2, H.S. Barbosa1, S.L. de
astro3
Instituto Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro,
razil
Instituto Oswaldo Cruz-FIOCRUZ, Rio de Janeiro, Brazil
Fundac¸ão Oswaldo Cruz, Rio de Janeiro, Brazil
Background: One hundred years after its discovery, Cha-
as disease, caused by Trypanosoma cruzi, still represents an
mportant health problem and in need of alternative drugs
or the treatment of chagasic.
Methods: Ethanolic extract of Brazilian green propolis
Et-Bra) was assayed on amastigotes proliferation, trypo-
astigote by transmission and scanning electron microscopy
nd ﬂow cytometry. Thirty two 1,3,4-thiadiazole-2-
rilhyldrazones of megazol were synthesized and assayed
n trypomastigotes.
Results: Et-Bra was active against amastigotes pro-
iferation inside mammalian macrophages and induced
lasma membrane damage in the infective trypomastigote
orms as determined by transmission and scanning elec-
ron microscopy and ﬂow cytometry. In non-infected mice,
ropolis induced no toxicity as determined by the GPT, GOT
nd CK plasma levels. Treatment of T. cruzi-infected mice
up to 300mg Et-Bra/kg/day for 10 days) led to a signiﬁcant
eduction of the mortality but not of the parasitemia, did
ot reversed the hepatic, renal or muscular damage induced
y the parasite.
Themost active analogues in vitro -S1 to S8- were assayed
n vivo by a single oral dose at 5 dpi, being selected S1,
2 and S3, together with megazol for subsequent in vitro
nd in vivo studies. In trypomastigotes, ultrastructural anal-
sis revealed that the compounds led to alterations at
DNA, mitochondrion and ﬂagellar membrane and rounding
nd torsion of the parasite’s body. S1 and S2 inhibited the
mastigotes proliferation inside macrophages, while in car-
iac muscular cells only S1 was active. The administration
f 10 consecutive doses (50 and 100mg/kg) of S1 caused no
ffect on the course of infection, while S2 led to a signiﬁcant
ecrease of the parasitemia and S3, only of the mortality.
he three analogues were not toxic for the animals based
n the levels of GPT, GOT and urea.
Conclusion: Our results demonstrate the promising activ-
ty on T. cruzi, especially S2 and S3, justifying in vivo assays
